apo-trifluridine ophthalmic solution
apotex inc - trifluridine - solution - 1% - trifluridine 1% - antivirals
sandoz trifluridine solution
sandoz canada incorporated - trifluridine - solution - 1% - trifluridine 1% - antivirals
trifluridine chauvin 1 pour cent, collyre
laboratoire chauvin - trifluridine - collyre - 1 g - composition pour 100 ml > trifluridine : 1 g
lonsurf
les laboratoires servier - trifluridine, tipiracil de chlorhydrate de - néoplasmes colorectaux - agents antinéoplasiques - colorectal cancerlonsurf is indicated in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (crc) who have received two prior anticancer treatment regimens including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and/or anti-egfr agents. lonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti egfr agentsgastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.
lonsurf comprimé
taiho pharma canada, inc. - trifluridine; tipiracil (chlorhydrate de tipiracil) - comprimé - 15mg; 6.14mg - trifluridine 15mg; tipiracil (chlorhydrate de tipiracil) 6.14mg - antineoplastic agents
lonsurf comprimé
taiho pharma canada, inc. - trifluridine; tipiracil (chlorhydrate de tipiracil) - comprimé - 20mg; 8.19mg - trifluridine 20mg; tipiracil (chlorhydrate de tipiracil) 8.19mg - antineoplastic agents
viroptic solution
bausch & lomb inc - trifluridine - solution - 1% - trifluridine 1% - antivirals
virophta, préparation pour collyre (lyophilisat et solvant)
horus pharma - trifluridine 0 - lyophilisat - 0,05 g - pour un flacon > trifluridine 0,05 g solvant > pas de substance active. - non renseignée. - ce médicament est un collyre contenant un antiviral actif contre l'herpès.il est préconisé dans le traitement d'atteintes oculaires herpétiques et de certaines inflammations de la cornée.
triherpine 1 pour cent, collyre
novartis pharma sas - trifluridine - collyre - 1 g - composition pour 100 ml > trifluridine : 1 g
lonsurf, 15 mg / 6,14 mg, comprimé pelliculé/ film coated tablet, boite de 20
les laboratoires servier - trifluridine + tipiracil - comprimé pelliculé/ film coated tablet - 15 mg / 6,14 mg